Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

The study found average numbers for different types of hair follicles in the scalp and observed differences between men and women, suggesting reasons for more common hair shedding in women.

A woman had temporary hair loss after a facelift, which improved on its own within a year.

Gasdermin A3 causes hair follicle stem cells to activate too early, leading to hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Certain long non-coding RNAs are important for controlling hair growth cycles in sheep.

Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.

Triphasic Progressive is more effective against hair loss.

A scalp biopsy revealed systemic amyloidosis in a woman who initially seemed to have a common hair loss condition.

Hair shedding that lasts more than 6 months may need medical tests, but often just reassurance is enough.

The document concludes that diagnosing hair loss requires evaluating multiple histological features, as no single feature is definitive on its own.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

The poem ends by asking for case reports on serious health issues like Telogen Effluvium.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Blocking Prostaglandin D₂ may help treat hair loss.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Etretinate therapy can cause hair loss by disrupting the hair growth cycle.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Lithium therapy may cause temporary hair loss, with possible regrowth if treatment is stopped or continued.

Oral contraceptives may cause hair loss in women.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

A horse's sudden hair loss was caused by an allergic reaction to a coat conditioning powder.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

The supplement may improve hair growth and skin health with some mild risks.

Melatonin may help regrow hair, but more consistent research is needed.